BB BIOTECH AG - Q1 2022 holdings

 Value Shares↓ Weighting
No holdings reported for quarter Q1 2022
Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
Celgene Corporation24Q1 201918.3%
Incyte Corporation24Q1 201915.3%
Gilead Sciences, Inc.24Q1 201914.2%
Vertex Pharmaceuticals Incorporated24Q1 20198.1%
Alexion Pharmaceuticals, Inc.24Q1 20195.7%
Halozyme Therapeutics, Inc.24Q1 20194.9%
Alnylam Pharmaceuticals, Inc.24Q1 20193.8%
Neurocrine Biosciences, Inc.23Q1 201910.3%
Regeneron Pharmaceuticals, Inc.22Q4 20183.5%
Achillion Pharmaceuticals, Inc.22Q3 20181.0%

View BB BIOTECH AG's complete holdings history.

Latest significant ownerships (13-D/G)

View BB BIOTECH AG's complete significant-ownership history.

Latest filings
TypeFiled
13F-NT2024-02-14
SC 13G/A2024-02-13
SC 13G/A2024-02-13
SC 13G/A2024-02-13
SC 13G/A2024-02-13
SC 13G/A2024-02-13
SC 13G/A2024-02-13
SC 13G/A2024-02-13
SC 13G/A2024-02-13
SC 13G/A2024-02-13

View BB BIOTECH AG's complete filings history.

Compare quarters

Export BB BIOTECH AG's holdings